Canine model for investigating the impact of oral enrofloxacin on commensal coliforms and colonization with multidrug-resistant Escherichia coli
Authors:
- 1 May 2004
- journal article
- research article
- Published by Microbiology Society in Journal of Medical Microbiology
- Vol. 53 (5) , 439-443
Abstract
A model was developed in dogs to determine the impact of oral enrofloxacin administration on the indigenous coliform population in the gastrointestinal tract and subsequent disposition to colonization by a strain of multidrug-resistant Escherichia coli (MDREC). Dogs given a daily oral dose of 5 mg enrofloxacin kg−1 for 21 consecutive days showed a significant decline in faecal coliforms to levels below detectable limits by 72 h of administration. Subsequently, faecal coliforms remained suppressed throughout the period of enrofloxacin dosing. Upon termination of antibiotic administration, the number of excreted faecal coliforms slowly returned over an 8-day period, to levels comparable to those seen prior to antibiotic treatment. Enrofloxacin-treated dogs were more effectively colonized by MDREC, evidenced by a significantly increased count of MDREC in the faeces (7.1 ± 1.5 log10 g−1) compared with non-antibiotic-treated dogs (5.2 ± 1.2; P = 0.003). Furthermore, antibiotic treatment also sustained a significantly longer period of MDREC excretion in the faeces (26.8 ± 10.5 days) compared with animals not treated with enrofloxacin (8.5 ± 5.4 days; P = 0.0215). These results confirm the importance of sustained delivery of an antimicrobial agent to maintain and expand the colonization potential of drug-resistant bacteria in vivo, achieved in part by reducing the competing commensal coliforms in the gastrointestinal tract to below detectable levels in the faeces. Without in vivo antimicrobial selection pressure, commensal coliforms dominated the gastrointestinal tract at the expense of the MDREC population. Conceivably, the model developed could be used to test the efficacy of novel non-antibiotic strategies aimed at monitoring and controlling gastrointestinal colonization by multidrug-resistant members of the Enterobacteriaceae that cause nosocomial infections.Keywords
This publication has 17 references indexed in Scilit:
- Unusual Salmonella enterica serotype Typhimurium isolate producing CMY-7, SHV-9 and OXA-30 beta-lactamasesJournal of Antimicrobial Chemotherapy, 2002
- Enrofloxacin resistance in Escherichia coli isolated from dogs with urinary tract infectionsJournal of the American Veterinary Medical Association, 2002
- Patterns and mechanisms of resistance to beta-lactams and beta-lactamase inhibitors in uropathogenic Escherichia coli isolated from dogs in PortugalJournal of Antimicrobial Chemotherapy, 2002
- Transmission of opportunistic pathogens in a veterinary teaching hospitalVeterinary Microbiology, 2001
- Canine Feces as a Reservoir of Extraintestinal PathogenicEscherichia coliInfection and Immunity, 2001
- Impact of Fluoroquinolone Administration on the Emergence of Fluoroquinolone-Resistant Gram-Negative Bacilli from Gastrointestinal FloraClinical Infectious Diseases, 2001
- Effect on the human normal microflora of oral antibiotics for treatment of urinary tract infectionsJournal of Antimicrobial Chemotherapy, 2000
- Emergence and Dissemination of Quinolone-Resistant Escherichia coli in the CommunityAntimicrobial Agents and Chemotherapy, 1999
- Effect of Quinolones on Intestinal EcologyDrugs, 1999
- The effect of quinolone antibacterials on the gastrointestinal flora compared with that of other antibacterialsJournal of Antimicrobial Chemotherapy, 1986